Artículo de Revisión Referencias 1.- Cosnes J, Gower-Rousseau C, Seksik 74 P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94. 2.- Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, et al. IBSEN Study Group. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis 2012; 18: 1540-9. 3.- Simian D, Estay C, Kronberg U, Yarur A, Castro M, Lubascher J, et al. Differences by age in clinical features of inflammatory bowel disease. Rev Med Chile 2015; 143: 689-96. 4.- Appleyard CB, Hernández G, Ríos-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004; 10: 106-11. 5.- Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol 2009; 46: 20-5. 6.- Yepes I, Carmona R, Díaz F, Marín- Jiménez. Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia. Rev Col Gastroenterol 2010; 25: 106-9. 7.- Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol 2016; 22: 5267-75. 8.- Husain A, Triadafilopoulos G. Communicating with patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 444-50. 9.- van der Eijk I, Vlachonikolis IG, Munkholm P, Nijman J, Bernklev T, Politi P, et al. EC-IBD Study Group. The role of quality of care in healthrelated quality of life in patients with IBD. Inflamm Bowel Dis 2004; 10: 392-8. 10.- Greenley RN, Kunz JH, Walter J, Hommel KA. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1534-45. 11.- Moradkhani A, Kerwin L, Dudley- Brown S, Tabibian JH. Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease. Dig Dis Sci 2011; 56: 2972-7. 12.- Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on health-care received. Rev Esp Enferm Dig 2004; 96: 174-84. 13.- Bregenzer N, Lange A, Fürst A, Gross V, Schölmerich J, Andus T. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being. Z Gastroenterol 2005; 43: 367-71. 14.- Rezailashkajani M, Roshandel D, Ansari S, Zali MR. Knowledge of disease and health information needs of the patients with inflammatory bowel disease in a developing country. Int J Colorectal Dis 2006; 21: 433-40. 15.- Subasinghe D, Wijekoon NS, Nawarathne NM, Samarasekera DN. Disease-related knowledge in inflammatory bowel disease: experience of a tertiary care centre in a developing country in South Asia. Singapore Med J 2010; 51: 484-9. 16.- Baars JE, Siegel CA, van’t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about their basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis 2010; 42: 777-84. 17.- Butcher RO, Law TL, Prudham RC, Limdi JK. Patient knowledge in inflammatory bowel disease: CCKNOW, how much do they know? Inflamm Bowel Dis 2011; 17: E131-2. 18.- Yoo YS, Cho OH, Cha KS. Diseaserelated knowledge and information needs among inflammatory bowel disease patients in Korea. Gastroenterol Nurs 2015; 38: 455-63. 19.- Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 615-22. 20.- Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn’s and Colitis Knowledge Score. Eur J Gastroenterol Hepatol 2014; 26: 1-5. 21.- Wardle RA, Mayberry JF. Has patient Educaci ón e n EII - D. Simian M. et al. knowledge of inflammatory bowel disease improved since 1999? Acta Gastroenterol Belg 2015; 78: 381-5. 22.- Simian D, Flores L, Quera R, Kronberg U, Ibáñez P, Figueroa C, et al. Assessment of disease-related knowledge and possible factors associated with the knowledge level among Chilean patients with inflammatory bowel disease. J Clin Nurs 2017; 26: 1508-15. 23.- Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005; 19: 235-44. 24.- Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010; 105: 525-39. 25.- Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 577-85. 26.- Kawakami A, Tanaka M, Naganuma M, Maeda S, Kunisaki R, Yamamoto-Mitani N. What strategies do ulcerative colitis patients employ to facilitate adherence? Patient Prefer Adherence 2017; 11: 157- 63. 27.- Bernick SJ, Kane S. Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients. Expert Rev Clin Immunol 2010; 6: 677- 82. 28.- Simian D, Quera R. Manejo integral de la enfermedad inflamatoria intestinal: más allá de una terapia farmacológica adecuada. Rev Med Chile 2016; 144: 488-95. 29.- Tae CH, Jung SA, Moon HS, Seo JA, Song HK, Moon CM, et al. Importance of patients’ knowledge of their prescribed medication in improving treatment adherence in inflammatory bowel disease. J Clin Gastroenterol 2016; 50: 157-62. 30.- Mocciaro F, Di Mitri R, Russo G, Leone S, Quercia V. Motivational interviewing in inflammatory bowel disease patients: a useful tool for outpatient counselling. Dig Liver Dis 2014; 46: 893-7. 31.- Ramdeen M, Poullis A, Gupta S, Ghosh D. Motivational interviewing to improve Gastroenterol. latinoam 2017; V ol 28, N º 2: 70-75
gastrolat 2 2017
To see the actual publication please follow the link above